Filing Flows › Emergent BioSolutions (EBS) › All other revenue revenue
Emergent BioSolutions (EBS) All other revenue revenue by quarter
Emergent BioSolutions' All other revenue revenue was $7.1M in Q3 2026 (third quarter 2026), -49% from Q2 2026. Over the last 7 quarters it ranged from $7.1M (Q3 2026) to $20.3M (Q1 2025).
| Quarter | All other revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $7.1M | -49% | -48% |
| Q2 2026 | $13.9M | +22% | -7% |
| Q1 2026 | $11.4M | +3% | -44% |
| Q4 2025 | $11.1M | -19% | — |
| Q3 2025 | $13.7M | -9% | — |
| Q2 2025 | $15.0M | -26% | — |
| Q1 2025 | $20.3M | — | — |
Q3 2026 at a glance
Emergent BioSolutions, Q3 2026: revenue $110M (-52% year over year), operating margin -33.9%, net loss $32.7M, operating cash flow $100M. The chart follows the revenue to costs, profit and cash.
Questions
What is Emergent BioSolutions' All other revenue revenue?
Emergent BioSolutions' All other revenue revenue was $7.1M in Q3 2026 (third quarter 2026), -49% from Q2 2026.
How has Emergent BioSolutions' All other revenue revenue changed?
Over the last 7 quarters it ranged from $7.1M (Q3 2026) to $20.3M (Q1 2025).